Indivior PLC, the pharmaceutical company that manufactures the opioid overdose antidote Opvee (nalmefene), has published new research showing that its…
On August 26, pharmaceutical manufacturer Indivior announced that it had begun supplying the Biomedical Advanced Research and Development Authority (BARDA)…
On August 7 the Food and Drug Administration approved an opioid overdose antidote developed by Purdue Pharma that contains nalmefene,…
Opvee, an opioid-overdose antidote manufactured by Indivior that was approved in 2023, has in recent weeks been slowly rolling out…